跳至主要内容
临床试验/ISRCTN69541857
ISRCTN69541857已完成未知

Effect of botulinum toxin A injections and specific intensive rehabilitation therapy in children with hemiparetic cerebral palsy on upper limb functions and skills

Ipsen Biopharm Ltd (UK)0 个研究点目标入组 60 人开始时间: 2008年3月31日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Aged 2.5 - 12 years, either sex
  • 2. Cerebral palsy
  • 3. Hagberg diagnosis: spastic hemiparesis or extreme asymmetric diplegia
  • 4. Hand function impairment Zancolli grade I with evident problems in thumb extension and supination, Zancolli grade IIA and IIB
  • 5. Mentally able to comprehend and perform tasks
  • 6. Children and their parents should be able to cope with the intensive rehabilitation therapy programme and the measurement sessions
  • 7. Children and the parents/caregivers should comprehend and speak Dutch
  • 8. Children and their parents indicate the necessity for improvement of the children's abilities

排除标准

  • 1. Severe structural contractures of the muscles at the extremity to be treated:
  • 1.1. Passive elbow extension maximum 160 degrees or less
  • 1.2. Supination maximum 30 degrees or less from neutral position
  • 1.3. Wrist dorsal flexion maximum 20 degrees or less in children aged 2.5 - 6 years, or 45 degrees or less in age group 7 - 12 years
  • 2. Severe impairment of hand function: no active hand function is expected after treatment (Zancolli III)
  • 3. Hand surgery or phenolisation or btA injections in the arm less than nine months ago
  • 4. Contraindication for botulinum toxin (muscular diseases such as myasthenia gravis, tetanus vaccination less than three months before the injection, use of aminoglycoside antibiotics or spectinomycine and known hypersensitivity for human albumin)
  • 5. Contraindication for anaesthesia
  • 6. Children who cannot bear touching the affected arm and hand

研究者

发起方
Ipsen Biopharm Ltd (UK)

相似试验

进行中(未招募)
不适用
Effect of Botulinum Toxin A Injections and Specific Intensive Rehabilitation Therapy in Children with Hemiparetic Cerebral Palsy on Upper Limb Functions and Skills - BoBiVa (Botuline toxine Bimanuele Vaardigheden)Study design: a factorial design with four study groups in which btA alone, intensive rehabilitation therapy aimed at improving bimanual skills alone, a combination of these two and continuing the regular therapy program will be compared to each other.Study population: children with CP, spastic hemiparesis, aged 2.5 – 12 years.
EUCTR2006-002175-40-NL60
已完成
3 期
Effect of Botulinum Toxin A Injections and Specific Intensive Rehabilitation Therapy in Children with Hemiparetic Cerebral Palsy on Upper Limb Functions and Skillscongenital hemiparesisSpastic hemiparetic cerebral palsy10010335
NL-OMON30186Hoensbroek Revalidatiecentrum (HRC)60
已完成
2 期
botulinum toxin type A and diabetic neuropathyDiabeticr polyneuropathy.Type 2 diabetes mellitus with diabetic polyneuropathyE10.42
IRCT20190129042540N1Rafsanjan University of Medical Sciences50
进行中(未招募)
不适用
The effect of botulinum toxin type A injections in the m. rectus femoris in stroke patients presenting with a stiff knee gait. - Botulinum toxin type A injections in stiff knee gaitStroke patients with stiff knee gait. Stiff knee gait is characterized as a diminished knee flexion during swing phase of gait. It is common in stroke patients.
EUCTR2009-018226-29-NL26
已完成
3 期
The effect of botulinum toxin type A injections in the m. rectus femoris in stroke patients presenting with stiff knee gaitstiff knee gaitstiff-legged knee1000796310057166
NL-OMON39359Revalidatiecentrum Het Roessingh26
Effect of botulinum toxin A injections and specific... | 临床试验